4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-021919
Chief Executive Officer sold 14,683 shares at $214.25 ($3,145,905)
- Chief Executive Officer acquired 14,683 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,683 | $84.98 | $1,247,761 | 455,482 | D |
| 2024-08-07 | Sale : show line 2 in the form 10b5-1 | −14,683 | $214.25 | $3,145,905 | 440,799 | D |
| Open-market sales · 14,683 sh · avg $214.25 · $3,145,905 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-07 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −14,683 | 44,049 | D |
Loading xslF345X05/form4.xml…